What, How, and How Much Should Patients with Burns be Fed?

Surgical Clinics of North America

Volumn 91, Issue 3, 2011, Pages 609-629

  Williams, Felicia N ^a   Branski, Ludwik K ^a   Jeschke, Marc G ^b   Herndon, David N ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

^b SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Burn injury; Hypermetabolic response; Nutrition; Trauma

Indexed keywords

ADRENALIN; AMINO ACID; ARACHIDONIC ACID; ASCORBIC ACID; CATECHOLAMINE; CYTOKINE; ENDOTOXIN; FATTY ACID; GLUCOSE; HUMAN GROWTH HORMONE; HYDROCORTISONE; INSULIN; INTERLEUKIN 1; INTERLEUKIN 6; IRON; LINOLEIC ACID; LIPID EMULSION; METFORMIN; NITRIC OXIDE; OXANDROLONE; PROPRANOLOL; REACTIVE OXYGEN METABOLITE; RETINOL; SELENIUM; SOMATOMEDIN C; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR; UNINDEXED DRUG; VITAMIN D; ZINC;

ACUTE KIDNEY FAILURE; BASAL METABOLIC RATE; BODY MASS; BURN; BURN PATIENT; DIET SUPPLEMENTATION; DRUG DOSE TITRATION; GLUCONEOGENESIS; GLUCOSE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HEART OUTPUT; HUMAN; HYPERGLYCEMIA; HYPERMETABOLISM; IMMUNE DEFICIENCY; IMMUNE RESPONSE; INFLAMMATION; INSULIN RESISTANCE; LOW FAT DIET; MILK; MORBIDITY; MORTALITY; MULTIPLE ORGAN FAILURE; NUTRITIONAL SUPPORT; OVERNUTRITION; PRIORITY JOURNAL; PROTEIN DEGRADATION; REVIEW; SEPSIS; SHOCK; TOTAL PARENTERAL NUTRITION; UREA NITROGEN BLOOD LEVEL; UREMIA; WEIGHT REDUCTION; WOUND HEALING;

ANIMALS; BLOOD GLUCOSE; BURNS; CATECHOLAMINES; ENTERAL NUTRITION; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN RESISTANCE; LIPOLYSIS; LIVER; METFORMIN; MULTIPLE ORGAN FAILURE; MUSCLE, SKELETAL; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION, TOTAL; WOUND HEALING;

EID: 79957556275     PISSN: 00396109     EISSN: 15583171     Source Type: Journal    
DOI: 10.1016/j.suc.2011.03.002     Document Type: Review

References (200)

1. Nguyen T.T., Gilpin D.A., Meyer N.A., et al. Current treatment of severely burned patients. Ann Surg 1996, 223(1):14-25.
2. Brigham P.A., McLoughlin E. Burn incidence and medical care use in the United States: estimates, trends, and data sources. J Burn Care Rehabil 1996, 17(2):95-107.
3. Wolf S. Critical care in the severely burned: organ support and management of complications. Total burn care 2007, 454-476. Saunders Elsevier, London. 3rd edition. D.N. Herndon (Ed.).
4. Herndon D.N., Tompkins R.G. Support of the metabolic response to burn injury. Lancet 2004, 363(9424):1895-1902.
5. Hart D.W., Wolf S.E., Mlcak R., et al. Persistence of muscle catabolism after severe burn. Surgery 2000, 128(2):312-319.
6. Reiss E., Pearson E., Artz C.P. The metabolic response to burns. J Clin Invest 1956, 35(1):62-77.
7. Yu Y.M., Tompkins R.G., Ryan C.M., et al. The metabolic basis of the increase in energy expenditure in severely burned patients. JPEN J Parenter Enteral Nutr 1999, 23(3):160-168.
8. Williams F.N., Jeschke M.G., Chinkes D.L., et al. Modulation of the hypermetabolic response to trauma: temperature, nutrition, and drugs. J Am Coll Surg 2009, 208(4):489-502.
9. Mlcak R.P., Jeschke M.G., Barrow R.E., et al. The influence of age and gender on resting energy expenditure in severely burned children. Ann Surg 2006, 244(1):121-130.
10. Przkora R., Barrow R.E., Jeschke M.G., et al. Body composition changes with time in pediatric burn patients. J Trauma 2006, 60(5):968-971.
11. Dolecek R. Endocrine changes after burn trauma-a review. Keio J Med 1989, 38(3):262-276.
12. Jeffries M.K., Vance M.L. Growth hormone and cortisol secretion in patients with burn injury. J Burn Care Rehabil 1992, 13(4):391-395.
13. Klein G.L., Bi L.X., Sherrard D.J., et al. Evidence supporting a role of glucocorticoids in short-term bone loss in burned children. Osteoporos Int 2004, 15(6):468-474.
14. Goodall M., Stone C., Haynes B.W. Urinary output of adrenaline and noradrenaline in severe thermal burns. Ann Surg 1957, 145(4):479-487.
15. Coombes E.J., Batstone G.F. Urine cortisol levels after burn injury. Burns Incl Therm Inj 1982, 8(5):333-337.
16. Norbury W.B., Herndon D.N. Modulation of the hypermetabolic response after burn injury. Total burn care 2007, 420-433. Saunders Elsevier, New York. 3rd edition. D.N. Herndon (Ed.).
17. Rutan R.L., Herndon D.N. Growth delay in postburn pediatric patients. Arch Surg 1990, 125(3):392-395.
18. Wilmore D.W., Mason A.D., Pruitt B.A. Insulin response to glucose in hypermetabolic burn patients. Ann Surg 1976, 183(3):314-320.
19. Goldstein D.S., Kopin I.J. Evolution of concepts of stress. Stress 2007, 10(2):109-120.
20. Selye H. Stress and the general adaptation syndrome. Br Med J 1950, 1(4667):1383-1392.
21. Selye H. An extra-adrenal action of adrenotropic hormone. Nature 1951, 168(4265):149-150.
22. Selye H., Fortier C. Adaptive reaction to stress. Psychosom Med 1950, 12(3):149-157.
23. Herndon D. Mediators of metabolism. J Trauma 1981, 21:701-705.
24. Lee J.O., Herndon D.N. Modulation of the post-burn hypermetabolic state. Nestle Nutr Workshop Ser Clin Perform Programme 2003, 8:39-49. [discussion: 49-56].
25. Newsome T.W., Mason A.D., Pruitt B.A. Weight loss following thermal injury. Ann Surg 1973, 178(2):215-217.
26. Barrow R.E., Hawkins H.K., Aarsland A., et al. Identification of factors contributing to hepatomegaly in severely burned children. Shock 2005, 24(6):523-528.
27. Barrow R.E., Wolfe R.R., Dasu M.R., et al. The use of beta-adrenergic blockade in preventing trauma-induced hepatomegaly. Ann Surg 2006, 243(1):115-120.
28. Herndon D.N., Hart D.W., Wolf S.E., et al. Reversal of catabolism by beta-blockade after severe burns. N Engl J Med 2001, 345(17):1223-1229.
29. Wolfe R.R., Herndon D.N., Peters E.J., et al. Regulation of lipolysis in severely burned children. Ann Surg 1987, 206(2):214-221.
30. Chang D.W., DeSanti L., Demling R.H. Anticatabolic and anabolic strategies in critical illness: a review of current treatment modalities. Shock 1998, 10(3):155-160.
31. Sheridan R.L. A great constitutional disturbance. N Engl J Med 2001, 345(17):1271-1272.
32. Pereira C., Murphy K., Jeschke M., et al. Post burn muscle wasting and the effects of treatments. Int J Biochem Cell Biol 2005, 37(10):1948-1961.
33. Wilmore D.W., Long J.M., Mason A.D., et al. Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg 1974, 180(4):653-669.
34. Jeschke M.G., Chinkes D.L., Finnerty C.C., et al. Pathophysiologic response to severe burn injury. Ann Surg 2008, 248(3):387-401.
35. Wilmore D.W., Aulick L.H. Metabolic changes in burned patients. Surg Clin North Am 1978, 58(6):1173-1187.
36. Wolfe R.R. Review: acute versus chronic response to burn injury. Circ Shock 1981, 8(1):105-115.
37. Cuthbertson D.P., Angeles Valero Zanuy M.A., Leon Sanz M.L. Post-shock metabolic response. 1942. Nutr Hosp 2001, 16(5):175-182.
38. Cuthbertson D. Post-shock metabolic response. Lancet 1942, (1):433-436.
39. Baron P.W., Barrow R.E., Pierre E.J., et al. Prolonged use of propranolol safely decreases cardiac work in burned children. J Burn Care Rehabil 1997, 18(3):223-227.
40. Williams F.N., Herndon D.N., Kulp G.A., et al. Propranolol decreases cardiac work in a dose-dependent manner in severely burned children. Surgery 2011, 149(2):231-239.
41. Galster A.D., Bier D.M., Cryer P.E., et al. Plasma palmitate turnover in subjects with thermal injury. J Trauma 1984, 24(11):938-945.
42. Cree M.G., Aarsland A., Herndon D.N., et al. Role of fat metabolism in burn trauma-induced skeletal muscle insulin resistance. Crit Care Med 2007, 35(Suppl 9):S476-S483.
43. Childs C., Heath D.F., Little R.A., et al. Glucose metabolism in children during the first day after burn injury. Arch Emerg Med 1990, 7(3):135-147.
44. Jeschke M.G., Mlcak R.P., Finnerty C.C., et al. Burn size determines the inflammatory and hypermetabolic response. Crit Care 2007, 11(4):R90.
45. Gauglitz G.G., Herndon D.N., Kulp G.A., et al. Abnormal insulin sensitivity persists up to three years in pediatric patients post-burn. J Clin Endocrinol Metab 2009, 94(5):1656-1664.
46. Khani S., Tayek J.A. Cortisol increases gluconeogenesis in humans: its role in the metabolic syndrome. Clin Sci (Lond) 2001, 101(6):739-747.
47. Wolfe R.R., Herndon D.N., Jahoor F., et al. Effect of severe burn injury on substrate cycling by glucose and fatty acids. N Engl J Med 1987, 317(7):403-408.
48. Gore D.C., Jahoor F., Wolfe R.R., et al. Acute response of human muscle protein to catabolic hormones. Ann Surg 1993, 218(5):679-684.
49. Robinson L.E., van Soeren M.H. Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues 2004, 15(1):45-62.
50. Gearhart M.M., Parbhoo S.K. Hyperglycemia in the critically ill patient. AACN Clin Issues 2006, 17(1):50-55.
51. Carlson G.L. Insulin resistance and glucose-induced thermogenesis in critical illness. Proc Nutr Soc 2001, 60(3):381-388.
52. Wolfe R.R., Durkot M.J., Allsop J.R., et al. Glucose metabolism in severely burned patients. Metabolism 1979, 28(10):1031-1039.
53. Cree M.G., Zwetsloot J.J., Herndon D.N., et al. Insulin sensitivity and mitochondrial function are improved in children with burn injury during a randomized controlled trial of fenofibrate. Ann Surg 2007, 245(2):214-221.
54. Hunt D.G., Ivy J.L. Epinephrine inhibits insulin-stimulated muscle glucose transport. J Appl Physiol 2002, 93(5):1638-1643.
55. Gustavson S.M., Chu C.A., Nishizawa M., et al. Interaction of glucagon and epinephrine in the control of hepatic glucose production in the conscious dog. Am J Physiol Endocrinol Metab 2003, 284(4):E695-E707.
56. Mastorakos G., Chrousos G.P., Weber J.S. Recombinant interleukin-6 activates the hypothalamic-pituitary-adrenal axis in humans. J Clin Endocrinol Metab 1993, 77(6):1690-1694.
57. Lang C.H., Dobrescu C., Bagby G.J. Tumor necrosis factor impairs insulin action on peripheral glucose disposal and hepatic glucose output. Endocrinology 1992, 130(1):43-52.
58. Akita S., Akino K., Ren S.G., et al. Elevated circulating leukemia inhibitory factor in patients with extensive burns. J Burn Care Res 2006, 27(2):221-225.
59. Fan J., Li Y.H., Wojnar M.M., et al. Endotoxin-induced alterations in insulin-stimulated phosphorylation of insulin receptor, IRS-1, and MAP kinase in skeletal muscle. Shock 1996, 6(3):164-170.
60. del Aguila L.F., Claffey K.P., Kirwan J.P. TNF-alpha impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells. Am J Physiol 1999, 276(5 Pt 1):E849-E855.
61. Sell H., Dietze-Schroeder D., Kaiser U., et al. Monocyte chemotactic protein-1 is a potential player in the negative cross-talk between adipose tissue and skeletal muscle. Endocrinology 2006, 147(5):2458-2467.
62. Baracos V., Rodemann H.P., Dinarello C.A., et al. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever. N Engl J Med 1983, 308(10):553-558.
63. Jahoor F., Desai M., Herndon D.N., et al. Dynamics of the protein metabolic response to burn injury. Metabolism 1988, 37(4):330-337.
64. Saffle J.R., Graves C. Nutritional support of the burned patient. Total burn care 2007, 398-419. Saunders Elsevier, London. 3rd edition. D.N. Herndon (Ed.).
65. Hart D.W., Wolf S.E., Chinkes D.L., et al. Determinants of skeletal muscle catabolism after severe burn. Ann Surg 2000, 232(4):455-465.
66. DeFronzo R.A., Jacot E., Jequier E., et al. The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 1981, 30(12):1000-1007.
67. Flakoll P.J., Hill J.O., Abumrad N.N. Acute hyperglycemia enhances proteolysis in normal man. Am J Physiol 1993, 265(5 Pt 1):E715-E721.
68. Arora N.S., Rochester D.F. Respiratory muscle strength and maximal voluntary ventilation in undernourished patients. Am Rev Respir Dis 1982, 126(1):5-8.
69. Greenhalgh D.G., Saffle J.R., Holmes J.H., et al. American Burn Association consensus conference to define sepsis and infection in burns. J Burn Care Res 2007, 28(6):776-790.
70. Murray C.K., Loo F.L., Hospenthal D.R., et al. Incidence of systemic fungal infection and related mortality following severe burns. Burns 2008, 34(8):1108-1112.
71. Pruitt B.A., McManus A.T., Kim S.H., et al. Burn wound infections: current status. World J Surg 1998, 22(2):135-145.
72. Williams F.N., Herndon D.N., Hawkins H.K., et al. The leading causes of death after burn injury in a single pediatric burn center. Crit Care 2009, 13(6):R183.
73. Im M.J., Hoopes J.E. Energy metabolism in healing skin wounds. J Surg Res 1970, 10(10):459-464.
74. Falcone P.A., Caldwell M.D. Wound metabolism. Clin Plast Surg 1990, 17(3):443-456.
75. Wilmore D.W., Aulick L.H., Mason A.D., et al. Influence of the burn wound on local and systemic responses to injury. Ann Surg 1977, 186(4):444-458.
76. Mochizuki H., Trocki O., Dominioni L., et al. Mechanism of prevention of postburn hypermetabolism and catabolism by early enteral feeding. Ann Surg 1984, 200(3):297-310.
77. Dominioni L., Trocki O., Fang C.H., et al. Enteral feeding in burn hypermetabolism: nutritional and metabolic effects of different levels of calorie and protein intake. JPEN J Parenter Enteral Nutr 1985, 9(3):269-279.
78. Wilmore D.W. Nutrition and metabolism following thermal injury. Clin Plast Surg 1974, 1(4):603-619.
79. Ireton-Jones C.S., Gottschlich M.M. The evolution of nutrition support in burns. J Burn Care Rehabil 1993, 14(2 Pt 2):272-280.
80. Popp M.B., Law E.J., MacMillian B.G. Parenteral nutrition in the burned child: a study of twenty-six patients. Ann Surg 1974, 179(2):219-225.
81. Curreri P.W., Richmond D., Marvin J., et al. Dietary requirements of patients with major burns. J Am Diet Assoc 1974, 65(4):415-417.
82. Wilmore D.W., Curreri P.W., Spitzer K.W., et al. Supranormal dietary intake in thermally injured hypermetabolic patients. Surg Gynecol Obstet 1971, 132(5):881-886.
83. Hildreth M.A., Herndon D.N., Desai M.H., et al. Reassessing caloric requirements in pediatric burn patients. J Burn Care Rehabil 1988, 9(6):616-618.
84. Herndon D.N., Barrow R.E., Stein M., et al. Increased mortality with intravenous supplemental feeding in severely burned patients. J Burn Care Rehabil 1989, 10(4):309-313.
85. Herndon D.N., Stein M.D., Rutan T.C., et al. Failure of TPN supplementation to improve liver function, immunity, and mortality in thermally injured patients. J Trauma 1987, 27(2):195-204.
86. Jeejeebhoy K.N. Total parenteral nutrition: potion or poison?. Am J Clin Nutr 2001, 74(2):160-163.
87. Wolf S.E., Rose J.K., Desai M.H., et al. Mortality determinants in massive pediatric burns. An analysis of 103 children with > or = 80% TBSA burns (> or = 70% full-thickness). Ann Surg 1997, 225(5):554-565. [discussion: 565-9].
88. Deitch E.A. Intestinal permeability is increased in burn patients shortly after injury. Surgery 1990, 107(4):411-416.
89. van Elburg R.M., Uil J.J., de Monchy J.G., et al. Intestinal permeability in pediatric gastroenterology. Scand J Gastroenterol Suppl 1992, 194:19-24.
90. Mochizuki H., Trocki O., Dominioni L., et al. Reduction of postburn hypermetabolism by early enteral feeding. Curr Surg 1985, 42(2):121-125.
91. McDonald W.S., Sharp C.W., Deitch E.A. Immediate enteral feeding in burn patients is safe and effective. Ann Surg 1991, 213(2):177-183.
92. Tinckler L.F. Surgery and intestinal motility. Br J Surg 1965, 52:140-150.
93. Moss G. Maintenance of gastrointestinal function after bowel surgery and immediate enteral full nutrition. II. Clinical experience, with objective demonstration of intestinal absorption and motility. JPEN J Parenter Enteral Nutr 1981, 5(3):215-220.
94. Goran M.I., Peters E.J., Herndon D.N., et al. Total energy expenditure in burned children using the doubly labeled water technique. Am J Physiol 1990, 259(4 Pt 1):E576-E585.
95. Gore D.C., Rutan R.L., Hildreth M., et al. Comparison of resting energy expenditures and caloric intake in children with severe burns. J Burn Care Rehabil 1990, 11(5):400-404.
96. Hart D.W., Wolf S.E., Herndon D.N., et al. Energy expenditure and caloric balance after burn: increased feeding leads to fat rather than lean mass accretion. Ann Surg 2002, 235(1):152-161.
97. Wolfe R.R., Allsop J.R., Burke J.F. Glucose metabolism in man: responses to intravenous glucose infusion. Metabolism 1979, 28(3):210-220.
98. Demling R.H., Seigne P. Metabolic management of patients with severe burns. World J Surg 2000, 24(6):673-680.
99. Mochizuki H., Trocki O., Dominioni L., et al. Optimal lipid content for enteral diets following thermal injury. JPEN J Parenter Enteral Nutr 1984, 8(6):638-646.
100. Garrel D.R., Razi M., Lariviere F., et al. Improved clinical status and length of care with low-fat nutrition support in burn patients. JPEN J Parenter Enteral Nutr 1995, 19(6):482-491.
101. Alexander J.W., Saito H., Trocki O., et al. The importance of lipid type in the diet after burn injury. Ann Surg 1986, 204(1):1-8.
102. Huschak G., Zur Nieden K., Hoell T., et al. Olive oil based nutrition in multiple trauma patients: a pilot study. Intensive Care Med 2005, 31(9):1202-1208.
103. Wolfe R.R., Goodenough R.D., Burke J.F., et al. Response of protein and urea kinetics in burn patients to different levels of protein intake. Ann Surg 1983, 197(2):163-171.
104. Yu Y.M., Young V.R., Castillo L., et al. Plasma arginine and leucine kinetics and urea production rates in burn patients. Metabolism 1995, 44(5):659-666.
105. Melville S., McNurlan M.A., McHardy K.C., et al. The role of degradation in the acute control of protein balance in adult man: failure of feeding to stimulate protein synthesis as assessed by L-[1-13C]leucin infusion. Metabolism 1989, 38(3):248-255.
106. Hoerr R.A., Matthews D.E., Bier D.M., et al. Effects of protein restriction and acute refeeding on leucine and lysine kinetics in young men. Am J Physiol 1993, 264(4 Pt 1):E567-E575.
107. Yu Y.M., Ryan C.M., Burke J.F., et al. Relations among arginine, citrulline, ornithine, and leucine kinetics in adult burn patients. Am J Clin Nutr 1995, 62(5):960-968.
108. Matthews D.E., Marano M.A., Campbell R.G. Splanchnic bed utilization of leucine and phenylalanine in humans. Am J Physiol 1993, 264(1 Pt 1):E109-E118.
109. Patterson B.W., Nguyen T., Pierre E., et al. Urea and protein metabolism in burned children: effect of dietary protein intake. Metabolism 1997, 46(5):573-578.
110. Soeters P.B., van de Poll M.C., van Gemert W.G., et al. Amino acid adequacy in pathophysiological states. J Nutr 2004, 134(Suppl 6):1575S-1582S.
111. De-Souza D.A., Greene L.J. Intestinal permeability and systemic infections in critically ill patients: effect of glutamine. Crit Care Med 2005, 33(5):1125-1135.
112. Souba W.W. Glutamine: a key substrate for the splanchnic bed. Annu Rev Nutr 1991, 11:285-308.
113. Gore D.C., Jahoor F. Glutamine kinetics in burn patients. Comparison with hormonally induced stress in volunteers. Arch Surg 1994, 129(12):1318-1323.
114. Garrel D. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns. JPEN J Parenter Enteral Nutr 2004, 28(2):123. [author reply: 123].
115. Wischmeyer P.E., Lynch J., Liedel J., et al. Glutamine administration reduces Gram-negative bacteremia in severely burned patients: a prospective, randomized, double-blind trial versus isonitrogenous control. Crit Care Med 2001, 29(11):2075-2080.
116. Zhou Y.P., Jiang Z.M., Sun Y.H., et al. The effect of supplemental enteral glutamine on plasma levels, gut function, and outcome in severe burns: a randomized, double-blind, controlled clinical trial. JPEN J Parenter Enteral Nutr 2003, 27(4):241-245.
117. Cerra F.B., Mazuski J.E., Chute E., et al. Branched chain metabolic support. A prospective, randomized, double-blind trial in surgical stress. Ann Surg 1984, 199(3):286-291.
118. Gamliel Z., DeBiasse M.A., Demling R.H. Essential microminerals and their response to burn injury. J Burn Care Rehabil 1996, 17(3):264-272.
119. Dietary Reference Intakes: The Essential Guide to Nutrient Requirements 2006, National Academic Press, Washington, DC. J.J. Otten, J. Pitzi-Hellwig, L.D. Meyers (Eds.).
120. Mayes T., Gottschlich M.M., Warden G.D. Clinical nutrition protocols for continuous quality improvements in the outcomes of patients with burns. J Burn Care Rehabil 1997, 18(4):365-368. [discussion: 364].
121. Ferrando A.A., Chinkes D.L., Wolf S.E., et al. A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg 1999, 229(1):11-18.
122. Gottschlich M.M., Mayes T., Khoury J., et al. Hypovitaminosis D in acutely injured pediatric burn patients. J Am Diet Assoc 2004, 104(6):931-941. [quiz: 1031].
123. Rock C.L., Dechert R.E., Khilnani R., et al. Carotenoids and antioxidant vitamins in patients after burn injury. J Burn Care Rehabil 1997, 18(3):269-278. [discussion: 268].
124. Selmanpakoglu A.N., Cetin C., Sayal A., et al. Trace element (Al, Se, Zn, Cu) levels in serum, urine and tissues of burn patients. Burns 1994, 20(2):99-103.
125. Hunt D.R., Lane H.W., Beesinger D., et al. Selenium depletion in burn patients. JPEN J Parenter Enteral Nutr 1984, 8(6):695-699.
126. Lee J. The pediatric burned patient. Total burn care 2007, 485-493. Saunders Elsevier, Philadelphia. 3rd edition. D.N. Herndon (Ed.).
127. Hart D.W., Wolf S.E., Zhang X.J., et al. Efficacy of a high-carbohydrate diet in catabolic illness. Crit Care Med 2001, 29(7):1318-1324.
128. Battistella F.D., Widergren J.T., Anderson J.T., et al. A prospective, randomized trial of intravenous fat emulsion administration in trauma victims requiring total parenteral nutrition. J Trauma 1997, 43(1):52-58. [discussion: 58-60].
129. Fong Y.M., Marano M.A., Barber A., et al. Total parenteral nutrition and bowel rest modify the metabolic response to endotoxin in humans. Ann Surg 1989, 210(4):449-456. [discussion: 456-7].
130. Askanazi J., Rosenbaum S.H., Hyman A.I., et al. Respiratory changes induced by the large glucose loads of total parenteral nutrition. JAMA 1980, 243(14):1444-1447.
131. Klein C.J., Stanek G.S., Wiles C.E. Overfeeding macronutrients to critically ill adults: metabolic complications. J Am Diet Assoc 1998, 98(7):795-806.
132. van den Berghe G., Wouters P., Weekers F., et al. Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345(19):1359-1367.
133. Turina M., Fry D.E., Polk H.C. Acute hyperglycemia and the innate immune system: clinical, cellular, and molecular aspects. Crit Care Med 2005, 33(7):1624-1633.
134. Shopbell J., Hopkins B., Shronts E. Nutrition screening and assessment. A case-based core curriculum 2001, Society of Parenteral and Enteral Nutrition, Silver Spring (MD). M.M. Gottschlich (Ed.).
135. Zdolsek H.J., Lindahl O.A., Angquist K.A., et al. Non-invasive assessment of intercompartmental fluid shifts in burn victims. Burns 1998, 24(3):233-240.
136. Graves C., Saffle J., Morris S. Comparison of urine urea nitrogen collection times in critically ill patients. Nutr Clin Pract 2005, 20(2):271-275.
137. Rettmer R.L., Williamson J.C., Labbe R.F., et al. Laboratory monitoring of nutritional status in burn patients. Clin Chem 1992, 38(3):334-337.
138. Jeschke M.G., Herndon D.N., Wolf S.E., et al. Recombinant human growth hormone alters acute phase reactant proteins, cytokine expression, and liver morphology in burned rats. J Surg Res 1999, 83(2):122-129.
139. Wu X., Herndon D.N., Wolf S.E. Growth hormone down-regulation of Interleukin-1beta and Interleukin-6 induced acute phase protein gene expression is associated with increased gene expression of suppressor of cytokine signal-3. Shock 2003, 19(4):314-320.
140. Jeschke M.G., Chrysopoulo M.T., Herndon D.N., et al. Increased expression of insulin-like growth factor-I in serum and liver after recombinant human growth hormone administration in thermally injured rats. J Surg Res 1999, 85(1):171-177.
141. Aili Low J.F., Barrow R.E., Mittendorfer B., et al. The effect of short-term growth hormone treatment on growth and energy expenditure in burned children. Burns 2001, 27(5):447-452.
142. Hart D.W., Herndon D.N., Klein G., et al. Attenuation of posttraumatic muscle catabolism and osteopenia by long-term growth hormone therapy. Ann Surg 2001, 233(6):827-834.
143. Herndon D.N., Barrow R.E., Kunkel K.R., et al. Effects of recombinant human growth hormone on donor-site healing in severely burned children. Ann Surg 1990, 212(4):424-429. [discussion: 430-1].
144. Branski L.K., Herndon D.N., Barrow R.E., et al. Randomized controlled trial to determine the efficacy of long-term growth hormone treatment in severely burned children. Ann Surg 2009, 250(4):514-523.
145. Klein G.L., Wolf S.E., Langman C.B., et al. Effects of therapy with recombinant human growth hormone on insulin-like growth factor system components and serum levels of biochemical markers of bone formation in children after severe burn injury. J Clin Endocrinol Metab 1998, 83(1):21-24.
146. Takala J., Ruokonen E., Webster N.R., et al. Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med 1999, 341(11):785-792.
147. Demling R.H. Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns 1999, 25(3):215-221.
148. Gore D.C., Honeycutt D., Jahoor F., et al. Effect of exogenous growth hormone on glucose utilization in burn patients. J Surg Res 1991, 51(6):518-523.
149. Ramirez R.J., Wolf S.E., Barrow R.E., et al. Growth hormone treatment in pediatric burns: a safe therapeutic approach. Ann Surg 1998, 228(4):439-448.
150. Moller S., Jensen M., Svensson P., et al. Insulin-like growth factor 1 (IGF-1) in burn patients. Burns 1991, 17(4):279-281.
151. Herndon D.N., Ramzy P.I., DebRoy M.A., et al. Muscle protein catabolism after severe burn: effects of IGF-1/IGFBP-3 treatment. Ann Surg 1999, 229(5):713-720. [discussion: 720-2].
152. Spies M., Wolf S.E., Barrow R.E., et al. Modulation of types I and II acute phase reactants with insulin-like growth factor-1/binding protein-3 complex in severely burned children. Crit Care Med 2002, 30(1):83-88.
153. Jeschke M.G., Herndon D.N., Barrow R.E. Insulin-like growth factor I in combination with insulin-like growth factor binding protein 3 affects the hepatic acute phase response and hepatic morphology in thermally injured rats. Ann Surg 2000, 231(3):408-416.
154. Cioffi W.G., Gore D.C., Rue L.W., et al. Insulin-like growth factor-1 lowers protein oxidation in patients with thermal injury. Ann Surg 1994, 220(3):310-316. [discussion: 316-9].
155. Langouche L., Van den Berghe G. Glucose metabolism and insulin therapy. Crit Care Clin 2006, 22(1):119-129. vii.
156. Hart D.W., Wolf S.E., Ramzy P.I., et al. Anabolic effects of oxandrolone after severe burn. Ann Surg 2001, 233(4):556-564.
157. Demling R.H., Orgill D.P. The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care 2000, 15(1):12-17.
158. Jeschke M.G., Finnerty C.C., Suman O.E., et al. The effect of oxandrolone on the endocrinologic, inflammatory, and hypermetabolic responses during the acute phase postburn. Ann Surg 2007, 246(3):351-360. [discussion: 360-2].
159. Demling R.H., DeSanti L. The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent. Burns 2001, 27(1):46-51.
160. Murphy K.D., Thomas S., Mlcak R.P., et al. Effects of long-term oxandrolone administration in severely burned children. Surgery 2004, 136(2):219-224.
161. Suman O.E., Thomas S.J., Wilkins J.P., et al. Effect of exogenous growth hormone and exercise on lean mass and muscle function in children with burns. J Appl Physiol 2003, 94(6):2273-2281.
162. Barret J.P., Jeschke M.G., Herndon D.N. Fatty infiltration of the liver in severely burned pediatric patients: autopsy findings and clinical implications. J Trauma 2001, 51(4):736-739.
163. Aarsland A., Chinkes D., Wolfe R.R., et al. Beta-blockade lowers peripheral lipolysis in burn patients receiving growth hormone. Rate of hepatic very low density lipoprotein triglyceride secretion remains unchanged. Ann Surg 1996, 223(6):777-787. [discussion: 787-9].
164. Gore D.C., Honeycutt D., Jahoor F., et al. Propranolol diminishes extremity blood flow in burned patients. Ann Surg 1991, 213(6):568-574.
165. Pereira C.T., Jeschke M.G., Herndon D.N. Beta-blockade in burns. Novartis Found Symp 2007, 280:238-251.
166. Pidcoke H.F., Wade C.E., Wolf S.E. Insulin and the burned patient. Crit Care Med 2007, 35(Suppl 9):S524-S530.
167. Pierre E.J., Barrow R.E., Hawkins H.K., et al. Effects of insulin on wound healing. J Trauma 1998, 44(2):342-345.
168. Thomas S.J., Morimoto K., Herndon D.N., et al. The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery 2002, 132(2):341-347.
169. Zhang X.J., Chinkes D.L., Wolf S.E., et al. Insulin but not growth hormone stimulates protein anabolism in skin would and muscle. Am J Physiol 1999, 276(4 Pt 1):E712-E720.
170. Jeschke M.G., Klein D., Herndon D.N. Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004, 239(4):553-560.
171. Jeschke M.G., Klein D., Bolder U., et al. Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology 2004, 145(9):4084-4093.
172. Jeschke M.G., Rensing H., Klein D., et al. Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol 2005, 42(6):870-879.
173. Klein D., Schubert T., Horch R.E., et al. Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg 2004, 240(2):340-349.
174. Gauglitz G.G., Toliver-Kinsky T.E., Williams F.N., et al. Insulin increases resistance to burn wound infection-associated sepsis. Crit Care Med 2010, 38(1):202-208.
175. Dandona P., Chaudhuri A., Mohanty P., et al. Anti-inflammatory effects of insulin. Curr Opin Clin Nutr Metab Care 2007, 10(4):511-517.
176. Van den Berghe G., Wilmer A., Hermans G., et al. Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354(5):449-461.
177. Finney S.J., Zekveld C., Elia A., et al. Glucose control and mortality in critically ill patients. JAMA 2003, 290(15):2041-2047.
178. Dellinger R.P., Levy M.M., Carlet J.M., et al. Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med 2008, 36(1):296-327.
179. Gore D.C., Wolf S.E., Herndon D.N., et al. Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma 2003, 54(3):555-561.
180. DeFronzo R.A., Goodman A.M. Efficacy of metformin in patients with non-insulin-dependent diabetes mellitus. The Multicenter Metformin Study Group. N Engl J Med 1995, 333(9):541-549.
181. Stumvoll M., Nurjhan N., Perriello G., et al. Metabolic effects of metformin in non-insulin-dependent diabetes mellitus. N Engl J Med 1995, 333(9):550-554.
182. Gore D.C., Herndon D.N., Wolfe R.R. Comparison of peripheral metabolic effects of insulin and metformin following severe burn injury. J Trauma 2005, 59(2):316-323.
183. Bailey C.J., Turner R.C. Metformin. N Engl J Med 1996, 334(9):574-579.
184. Luft D., Schmulling R.M., Eggstein M. Lactic acidosis in biguanide-treated diabetics: a review of 330 cases. Diabetologia 1978, 14(2):75-87.
185. Heszele M.F.C., Price S.R. Insulin-like growth factor I: the yin and yang of muscle atrophy. Endocrinology 2004, 145(11):4803-4805.
186. Barret J.P., Dziewulski P., Jeschke M.G., et al. Effects of recombinant human growth hormone on the development of burn scarring. Plast Reconstr Surg 1999, 104(3):726-729.
187. Takagi K., Suzuki F., Barrow R.E., et al. Recombinant human growth hormone modulates Th1 and Th2 cytokine response in burned mice. Ann Surg 1998, 228(1):106-111.
188. Takagi K., Suzuki F., Barrow R.E., et al. Growth hormone improves immune function and survival in burned mice infected with Herpes simplex virus type?. J Surg Res 1997, 69(1):166-170.
189. Low J.F.A., Herndon D.N., Barrow R.E. Effect of growth hormone on growth delay in burned children: a 3-year follow-up study. Lancet 1999, 354(9192):1789.
190. Demling R.H., DeSanti L. Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma 1997, 43(1):47-51.
191. Aarsland A., Chinkes D.L., Sakurai Y., et al. Insulin therapy in burn patients does not contribute to hepatic triglyceride production. J Clin Invest 1998, 101(10):2233-2239.
192. Minnich A., Tian N., Byan L., et al. A potent PPAR alpha agonist stimulates mitochondrial fatty acid beta-oxidation in liver and skeletal muscle. Am J Physiol Endocrinol Metab 2001, 280(2):E270-E279.
193. Schnabel D., Grasemann C., Staab D., et al. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis. Pediatrics 2007, 119(6):E1230-E1238.
194. Herndon D.N., Barrow R.E., Rutan T.C., et al. Effect of propranolol administration on hemodynamic and metabolic responses of burned pediatric patients. Ann Surg 1988, 208(4):484-492.
195. Engelhardt D., Dorr G., Jaspers C., et al. Ketoconazole blocks cortisol secretion in man by inhibition of adrenal 11-beta-hydroxylase. Klin Wochenschr 1985, 63(13):607-612.
196. Engelhardt D., Mann K., Hormann R., et al. Ketoconazole inhibits cortisol secretion of an adrenal adenoma in vivo and in vitro. Klin Wochenschr 1983, 61(7):373-375.
197. Loose D.S., Stover E.P., Feldman D. Ketoconazole binds to glucocorticoid receptors and exhibits glucocorticoid antagonist activity in cultured cells. J Clin Invest 1983, 72(1):404-408.
198. Hart D.W., Wolf S.E., Chinkes D.L., et al. Beta-blockade and growth hormone after burn. Ann Surg 2002, 236(4):450-457.
199. Jeschke M.G., Finnerty C.C., Kulp G.A., et al. Combination of recombinant human growth hormone and propranolol decreases hypermetabolism and inflammation in severely burned children. Pediatr Crit Care Med 2008, 9(2):209-216.
200. Debroy M.A., Wolf S.E., Zhang X.J., et al. Anabolic effects of insulin-like growth factor in combination with insulin-like growth factor binding protein-3 in severely burned adults. J Trauma 1999, 47(5):904-910.